Maria L. Maccecchini

Author

Also Known As

M L Maccecchini, M. L. Maccecchini, M.-L. Maccecchini, M.L. Maccecchini, M.‐L. MACCECCHINI, Maria L Maccecchini, Maria L. Maccecchini, Maria Luisa MACCECCHINI, Maria Maccecchini, Maria-Luisa Maccecchini

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

QR Pharma (United States)University of California San Diego University of Minnesota Columbia University Massachusetts General Hospital

About

Maria L. Maccecchini is an author at QR Pharma (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	805
2	Biochemistry	5	5	685
3	Natural Sciences	3	3	627
4	Health Sciences	2	2	55
5	Engineering	1	1	77

Maria L. Maccecchini

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Import of proteins into mitochondria: precursor forms of the extramitochondrially made F1-ATPase subunits in yeast. Maria L. Maccecchini, Y. Rudin, G Blobel, Proceedings of the National Academy of Sciences BiosynthesisLargest Atpase SubunitsMitochondrial BiogenesisBiochemistryMitochondrial Function	1979	457
Transport of proteins across the mitochondrial outer membrane. A precursor form of the cytoplasmically made intermembrane enzyme cytochrome c peroxidase. Maria L. Maccecchini, Y. Rudin, Gottfried Schatz Journal of Biological Chemistry Molecular BiologyMitochondrial BiologyRedox BiologyCytochrome C PeroxidaseMembrane Fusion	1979	95
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans Maria L. Maccecchini, Mee Young Chang, Catherine Pan, Journal of Neurology Neurosurgery & Psychiatry	2012	85
The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen Jack T. Rogers, Sohan Mikkilineni, Ippolita Cantuti‐Castelvetri, Journal of Neural Transmission Translational MedicineEngineeringMedicineTranslation BlockersTranslational Research	2011	77
Synthesis, Resolution, and Biological Evaluation of the Four Stereoisomers of 4-Methylglutamic Acid: Selective Probes of Kainate Receptors Z.‐Q. GU, David P. Hesson, Jeffrey C. Pelletier, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryAltmetric Attention ScoreOrganic ChemistryChemical Biology	1995	75
Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model Xu‐Qiao Chen, Ahmad Salehi, Matthew L. Pearn, Alzheimer s & Dementia	2020	52
Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist Peggy J. Chandler, Michael W. Pennington, Maria L. Maccecchini, Journal of Biological Chemistry Molecular PharmacologyNmda Receptor ComplexBiochemistryMedicineModified Conantokin-g Derivatives	1993	46
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse Andrew F. Teich, Ekta Sharma, Eliza Barnwell, Alzheimer s & Dementia Translational Research & Clinical Interventions	2018	42
The kainate receptor antagonist 2S,4R-4-methylglutamate attenuates mechanical allodynia and thermal hyperalgesia in a rat model of nerve injury Jessie L. Sutton, Maria L. Maccecchini, Keith C. Kajander Neuroscience Health SciencesThermal HyperalgesiaMedicinePhysiologyAnesthetic Mechanism	1999	41
Translational inhibition of α-synuclein by Posiphen normalizes distal colon motility in transgenic Parkinson mice. Yien–Ming Kuo, Ejike Innocent Nwankwo, Robert L. Nussbaum, PubMed	2019	31

Page 1